Gruenberg, a division of Thermal Product Solutions (TPS, LLC) is pleased to announce that the recent FDA enforcement policy supports the use of Gruenberg dry heat sterilizers for bioburden reduction on N95 respirators during the Coronavirus (COVID-19) public health emergency. The FDA guidance document [1] supports the use of dry heat processing to reduce the risk of transmission of the SARS-CoV-2 virus and supports limited reuse of NIOSH approved Filtering Facepiece Respirators. The FDA policy states that “Based on currently available evidence, dry heat at T = 75 °C for t=30 minutes should reliably achieve ≥ 3-log reduction in non-enveloped
